Wolters Kluwer, Health has announced that Christopher Sullivan has been appointed as Vice President and General Manager of the Commercial Segment for Clinical Effectiveness.
In his 11 years at Wolters Kluwer, Sullivan has held a range of leadership positions in strategy, product management, pricing, and strategic partnerships. Most recently he served as Vice President and General Manager of the Transactional & Retirement Portfolio in Wolters Kluwer’s Legal & Regulatory division, where he oversaw a portfolio of SaaS solutions and expert content serving legal and compliance professionals.
In his new role, Sullivan will lead the Commercial Segment with responsibility for setting strategy and driving growth of its clinical decision support (CDS) solutions including Medi-Span®, Lexicomp®, UpToDate® and Emmi®. The segment provides expert content and workflow tools to professionals in the pharmacy, digital health technology, and commercial payer markets.
Sullivan reports to Greg Samios, President and CEO of Clinical Effectiveness, Wolters Kluwer, Health.
Click here to read the original press release.
